{"name":"Apomorphine","slug":"apomorphine","kind":"substance","abbreviations":[],"systematic":null,"aliases":["L-Apomorphine","Apomorfin","Apomorphin","R-(-)-Apomorphine","Ixense","(-)-Apomorphine","6aβ-Aporphine-10,11-diol","Apomorphinum","(-)-10,11-Dihydroxyaporphine","Vr-040"],"brands":[],"scraped":true,"has_structure":true,"cid":6005,"classes":[],"families":[{"name":"1,2-diarylethylamine","href":"/substituted/1,2-diarylethylamine"}],"physical":[{"label":"Molecular mass","value":"267.32 g/mol","copyable":false},{"label":"Appearance","value":"Hexagonal plates from chloroform+petroleum ether; rods from ether","copyable":false},{"label":"Melting point","value":"195 °C (decomposes)","copyable":false},{"label":"Decomposition","value":"When heated to decomposition it emits highly toxic fumes of nitroxides.","copyable":false},{"label":"Solubility","value":"MINUTE, WHITE OR GRAYISH WHITE, GLISTENING CRYSTALS OR WHITE POWDER; ODORLESS; SOLN ARE NEUTRAL TO LITMUS; LEVOROTATORY IN DIL ACID; 1 G SOL IN 50 ML WATER, IN ABOUT 50 ML ALCOHOL, &amp; IN ABOUT 20 ML WATER @ 80 °C; PPT BY TANNIC ACID &amp; OTHER ALKALOIDAL PRECIPITANTS &amp; DECOMP BY OXIDIZING AGENTS. /HCL/","copyable":false},{"label":"Predicted LogP","value":"2.3","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>17</sub>H<sub>17</sub>NO<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol","copyable":true},{"label":"SMILES","value":"CN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=C(C=C4)O)O","copyable":true},{"label":"InChI","value":"InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m1/s1","copyable":true},{"label":"InChIKey","value":"VMWNQDUVQKEIOC-CYBMUJFWSA-N","copyable":true},{"label":"CAS number","value":"58-00-4","copyable":true},{"label":"UNII","value":"N21FAR7B4S","copyable":true},{"label":"PubChem CID","value":"6005","copyable":true}],"pharmacokinetics":[{"label":"Onset","value":"10–20 min","copyable":false},{"label":"Elimination half-life","value":"40 minutes","copyable":false},{"label":"Duration of action","value":"60–90 min","copyable":false},{"label":"Metabolism","value":"Liver, phase II","copyable":false},{"label":"Excretion","value":"Liver","copyable":false},{"label":"Routes of administration","value":"Subcutaneous, sublingual","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Mouse",[{"kind":"LD50","organism":"Mouse","route":"oral","dose":"300 mg/kg"},{"kind":"LD50","organism":"Mouse","route":"ip","dose":"160 mg/kg"},{"kind":"LD50","organism":"Mouse","route":"iv","dose":"56 mg/kg"},{"kind":"LD50","organism":"Mouse","route":"Intraperitoneal","dose":"0.6 mmoles/kg"}]]]}],"dosing":null,"salts":[{"title":"Apomorphine dihydrochloride","name":"dihydrochloride","slug":"apomorphine_dihydrochloride","drawn":true},{"title":"Apomorphine hydrochloride","name":"hydrochloride","slug":"apomorphine_hydrochloride","drawn":true}],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":"( - )","stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"G","description":"Genito urinary system and sex hormones"},{"code":"G04","description":"Urologicals"},{"code":"G04B","description":"Urologicals"},{"code":"G04BE","description":"Drugs used in erectile dysfunction"},{"code":"G04BE07","description":"Apomorphine"},{"code":"N","description":"Nervous system"},{"code":"N04","description":"Anti-parkinson drugs"},{"code":"N04B","description":"Dopaminergic agents"},{"code":"N04BC","description":"Dopamine agonists"},{"code":"N04BC07","description":"Apomorphine"}],"mesh":[{"name":"Emetics","id":"M0007280"},{"name":"Dopamine Agonists","id":"M0027733"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"DRD2","mechanisms":["shared target"],"partners":188,"contraindicated":0},{"target":"DRD1","mechanisms":["shared target"],"partners":23,"contraindicated":0}],"mechanism":"Apomorphine is a non-ergoline dopamine agonist with high binding affinity to dopamine D2, D3, and D5 receptors. Stimulation of D2 receptors in the caudate-putamen, a region of the brain responsible for locomotor control, may be responsible for apomorphine's action. However, the means by which the cellular effects of apomorphine treat hypomobility of Parkinson's remain unknown.","side_effects":{"drug_id":2215,"drug_name":"apomorphine","url":"https://sideeffects.embl.de/drugs/2215/pt","atc_codes":["G04BE07","N04BC07"],"side_effects":[{"name":"Yawning","cui":"C0043387"},{"name":"Somnolence","cui":"C2830004"},{"name":"Dyskinesia","cui":"C0013384"},{"name":"Nausea","cui":"C0027497"},{"name":"Vomiting","cui":"C0042963"},{"name":"Dizziness","cui":"C0012833"},{"name":"Syncope","cui":"C0039070"},{"name":"Orthostatic hypotension","cui":"C0020651"},{"name":"Nasopharyngitis","cui":"C0027441"},{"name":"Rhinorrhoea","cui":"C1260880"},{"name":"Contusion","cui":"C0009938"},{"name":"Angina pectoris","cui":"C0002962"},{"name":"Chest pain","cui":"C0008031"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Oedema","cui":"C0013604"},{"name":"Hallucination","cui":"C0018524"},{"name":"Swelling","cui":"C0038999"},{"name":"Granuloma","cui":"C0018188"},{"name":"Pruritus","cui":"C0033774"},{"name":"Anxiety","cui":"C0003467"},{"name":"Arthralgia","cui":"C0003862"},{"name":"Musculoskeletal discomfort","cui":"C0948594"},{"name":"Asthenia","cui":"C0004093"},{"name":"Fatigue","cui":"C0015672"},{"name":"Back pain","cui":"C0004604"},{"name":"Mental disorder","cui":"C0004936"},{"name":"Constipation","cui":"C0009806"},{"name":"Dehydration","cui":"C0011175"},{"name":"Diarrhoea","cui":"C0011991"},{"name":"Dyspnoea","cui":"C0013404"},{"name":"Ecchymosis","cui":"C0013491"},{"name":"Flushing","cui":"C0016382"},{"name":"Headache","cui":"C0018681"},{"name":"Cardiac failure congestive","cui":"C0018802"},{"name":"Hypotension","cui":"C0020649"},{"name":"Libido increased","cui":"C0021177"},{"name":"Disturbance in sexual arousal","cui":"C0855242"},{"name":"Pain in extremity","cui":"C0030196"},{"name":"Pallor","cui":"C0030232"},{"name":"Pathological gambling","cui":"C0030662"},{"name":"Pneumonia","cui":"C0032285"},{"name":"Priapism","cui":"C0033117"},{"name":"Psychotic disorder","cui":"C0033975"},{"name":"Shock","cui":"C0036974"},{"name":"Loss of consciousness","cui":"C0041657"},{"name":"Urinary tract infection","cui":"C0042029"},{"name":"Injection site reaction","cui":"C0151735"},{"name":"Hypersexuality","cui":"C0312420"},{"name":"Hyperhidrosis","cui":"C0020458"},{"name":"Parkinson's disease","cui":"C0030567"},{"name":"Insomnia","cui":"C0917801"}],"indications":[{"name":"Parkinson's disease","cui":"C0030567"}]},"effects":null,"usernotes":[{"user":"emily","user_slug":"emily","external":false,"note":{"substance":"Apomorphine","composite":false,"routes":[{"name":"oral","dosage":"8-20mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"United Kingdom","status":"Prescription only","act":null,"refs":[]},{"jurisdiction":"United States","status":"Prescription only","act":null,"refs":[4]},{"jurisdiction":"Other","status":"Rx-only","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Apomorphine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/6005"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q269111"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00714"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL53"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A48538"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=58-00-4"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014852"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D07460"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID8022614"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Apomorphine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/N21FAR7B4S"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/2215/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 6005, Apomorphine. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/6005>https://pubchem.ncbi.nlm.nih.gov/compound/6005</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Apomorphine. UNII: N21FAR7B4S. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/N21FAR7B4S>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/N21FAR7B4S</a>","Movapo Pod (Stada Pharmaceuticals Australia Pty Ltd). Therapeutic Goods Administration (TGA). 13 September 2024. <a href='https://www.tga.gov.au/resources/prescription-medicines-registrations/movapo-pod-stada-pharmaceuticals-australia-pty-ltd'>https://www.tga.gov.au/resources/prescription-medicines-registrations/movapo-pod-stada-pharmaceuticals-australia-pty-ltd</a>","Onapgo- apomorphine hydrochloride injection, solution. DailyMed. 28 February 2025. <a href='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f3552b6e-5ae7-4993-aa1a-e399c4a7080a'>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f3552b6e-5ae7-4993-aa1a-e399c4a7080a</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 06:18:09","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 06:18:05","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 06:18:05","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 06:18:07","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 06:18:05","note":"hmdb.ca refused automated access to HMDB0014852"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 06:18:08","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 06:18:04","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 06:18:05","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 06:18:05","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 06:18:05","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 06:18:05","note":null}],"description":"Apomorphine is a  substance."}